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LETTERS TO THE EDITORRegarding “Prediction of 30-day mortality after
endovascular repair or open surgery in patients with
ruptured abdominal aortic aneurysms”
We read with interest the article by Dr Visser and colleagues.1
The Glasgow Aneurysm Score (GAS) was described in 1994 as
a tool for prognostic scoring in patients undergoing open repair of
either intact or ruptured abdominal aortic aneurysm (AAA). A
retrospective, multicentred, nonconsecutive sample of 500 pa-
tients undergoing aneurysm repair at general surgical units in
Glasgow between 1980 and 1990 was examined for risk factors
associated with death.2 Recently, this risk-scoring instrument has
been the subject of external validation. When applied to our own
series’ of both retrospective and prospective data on patients
undergoing attempted repair of ruptured AAA, the instrument
performed with moderate accuracy at best, and lacked discrimina-
tive ability in patients at high risk.3,4 Furthermore, when the
instrument is applied to endovascular repair of intact aneurysms,
the tool is found wanting too. Suboptimal performance was found
in a retrospective series from London, and the prospective data of
the DREAM trial noted poor validity in high risk patients.5,6
The poor performance of the GAS in contemporary series of
patients undergoing AAA repair is unsurprising given the origins of
the dataset with which it was modeled – patients treated with open
surgery in low-volume, nonspecialist, general surgical units more
than 20 years ago. To expect this risk-scoring instrument to
demonstrate validity, despite the existing reports questioning its
precision, on a series of patients undergoing open and endovascu-
lar repair of ruptured AAA is hopeful to say the least. However, to
attempt to refine the performance of the tool, so that it better fits
the reported data, seems intrinsically flawed.
The GAS was never intended for application in patients un-
dergoing endovascular aneurysm repair and lacks validity in high-
risk patients. Fifteen years from its conception, perhaps it is time to
acknowledge these deficiencies and accept that it is no longer fit for
purpose. Valuable data, such as those of the 4-A group, may be
better utilized to develop novel, original risk scoring instruments.
Elaine Yeap, MBChB
Andrew L. Tambyraja, MD
Roderick T. A. Chalmers, MD
Edinburgh Vascular Surgical Service
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
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Reply
We would like to thank Tambyraja and colleagues for their
valuable comments about our manuscript. It should be men-
tioned that, when developing a prognostic tool, two main
approaches could be followed. First, a new regression model can
be developed. Second, a former published regression model can
be updated. It is acknowledged from a statistical point of view
that updating a previously published model is preferred.1 There-
fore, we chose to update the previously published Glasgow
Aneurysm Score in stead of developing a new model. However,
we encourage further validation and updating of our prediction
rule.
Jacob J. Visser, MD, PhD
Marc R.H.M. van Sambeek, MD, PhD
Erasmus MC
Rotterdam, The Netherlands
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Regarding “Identification of a genetic variant
associated with abdominal aortic aneurysms on
chromosome 3p12.3 by genome wide association”
We read with interest the study by Elmore and colleagues,
which reported an association between a region on chromosome 3
and abdominal aortic aneurysm (AAA). We were intrigued to see if
this association was also present in our New Zealand AAA cohort.
An in silico validation was performed using 567 cases and 552
screened controls1 that have been genotyped using Affymetrix
Genome-Wide Human SNP Array 6.0. We could not replicate the
reported association with rs7635818. Nor was there any associa-
tion with neighboring SNPs. Nevertheless, we also examined SNPs
in the region of CNTN3, the nearest gene to the locus identified by
Elmore et al. Three SNPs within intron 2 showed suggestive
associations with AAA (Table), though these were of weak effect
and would not be considered significant when multiple testing is
taken into consideration.
While we do not discount the possibility that the suggested
chromosome 3 locus is truly associated with AAA, we would advise
caution with regard to this result. The lack of association with our
